What Health Care Providers Should Know About Using Compounded Semaglutide

Compounded semaglutide products may pose risks due to potential quality control issues.

• The popularity of semaglutide has led to nationwide shortages of FDA-approved products for diabetes and obesity.
• High costs and access restrictions have resulted in increased demand for compounded versions of semaglutide.
• Compounded products may not meet the same quality standards as FDA-approved formulations, raising concerns about safety and efficacy.
• There have been reports of fraudulent compounded semaglutide products in the global market.
• Health care providers can play a critical role in guiding patients to safe sources of compounded semaglutide and advising on proper usage.

Simplified